Skip to main content

Table 1 Patient demographic and clinical characteristics

From: Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation

All patients

60

Characteristic

Mean age at surgery (range, years)

62.5 ± 7.5 (33–72)

Sex

 Male

49 (81.7)

 Female

11 (18.3)

Cause of chronic liver disease

 HCV

20 (33.3)

 HBV

16 (26.7)

 Alcohol

11 (18.3)

 NASH

9 (15)

 Other

4 (6.7)

LRT (per patient)

46 (76.7)

Type of LRT (per lesion)

 Total number of treated observations

134 (100)

 RFA

78 (58.2)

 TACE

15 (11.2)

 TACE and RFA

29 (21.7)

 BE

4 (3)

 MWA

3 (2.2)

 SBRT

1 (0.7)

 Not specified

4 (3)

Type of liver transplantation

 Living donor

5 (8.3)

 Deceased donor

55 (91.7)

Time interval (day)

Mean (SD), Median (range)

CT and EOB-MRI

90.3 (41.4), 84.5 (0.0–271.0)

CT and LT

100.7 (63.9), 101.5 (0.0–279.0)

EOB-MRI and LT

69.1 (49.7), 61 (3–192)

Last imaging and LT

39.8 (28.9), 35 (0–110)

  1. Data in parentheses are numbers used to calculate the percentages
  2. BE bland embolization, LRT local-regional therapy, MWA microwave ablation, RFA radiofrequency ablation, SBRT stereotactic body radiation therapy, TACE transarterial chemoembolization